Women's Health

Allergan plans sales of women's health, infectious disease units
Reuters
Wed, 05/30/18 - 11:57 am
Allergan
M&A
Women's Health
infectious diseases
Allergan toys with $5B women's health sale to boost bottom-feeding shares
Fierce Pharma
Tue, 04/3/18 - 12:00 pm
Allergan
Women's Health
M&A
Teva closes $703m sale of global women’s health biz to CVC Capital
Drug Delivery Business News
Thu, 02/1/18 - 09:28 am
Teva Pharmaceutical
Women's Health
M&A
CVC Capital
Women’s health biotech KaNDy dickering with Allergan about a $400M buyout deal — report
Endpoints
Fri, 01/26/18 - 09:05 am
Women's Health
KaNDy
Allergan
M&A
Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline
Endpoints
Tue, 12/12/17 - 11:18 am
Allergan
Repros
M&A
Women's Health
Drug prices, the fate of Obamacare, and women’s health: How Alex Azar would shape HHS
Stat
Tue, 12/5/17 - 06:33 pm
drug pricing
Women's Health
Obamacare
healthcare reform
HHS
Alex Azar
Eli Lilly
Allergan could sell women's health for $6B, if it would only agree to split: analyst
Fierce Pharma
Tue, 11/21/17 - 11:46 am
Allergan
Women's Health
M&A
Cash-strapped Teva closes in on women's health sale No. 2: report
Fierce Pharma
Fri, 09/15/17 - 11:27 am
Teva Pharmaceutical
Women's Health
M&A
CVC
Bidders line up for Teva's women's health unit in potential $2B sale
Fierce Pharma
Tue, 08/22/17 - 06:50 pm
Teva Pharmaceutical
M&A
Women's Health
Intas Pharmaceuticals offered $1.5bn for 3 divisions of Teva’s in Europe
GoInPharma
Mon, 08/14/17 - 10:04 am
Intas
India
M&A
Teva Pharmaceutical
Europe
Women's Health
oncology
pain management
Teva sells as many as 4 assets: Medis, respiratory, women’s health and oncology
GoInPharma
Fri, 08/11/17 - 11:42 am
Teva Pharmaceutical
M&A
Respiratory
Women's Health
oncology
Medis
Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets
Motley Fool
Fri, 05/12/17 - 11:46 am
Teva Pharmaceutical
M&A
Women's Health
oncology
Teva, still searching for 'world-class' CEO, officially puts women's health, cancer on the block
Fierce Pharma
Thu, 05/11/17 - 06:28 pm
Teva Pharmaceutical
Pharma CEOs
M&A
Women's Health
oncology
3 Reasons Teva Pharmaceutical Industries Lost Another $520 Million in Market Value in April
Fierce Pharma
Wed, 05/3/17 - 10:13 am
Teva Pharmaceutical
bribery
Women's Health
oncology
reorganization
Debt-laden Teva, looking for cash, weighs $2B women's health sale: report
Fierce Pharma
Mon, 04/10/17 - 10:17 am
Teva Pharmaceutical
M&A
Women's Health
Birth Control Can Protect Women From Certain Cancers For Decades
Forbes
Mon, 03/27/17 - 10:53 am
birth control pill
contraceptives
Women's Health
FDA touts own role in women's heart health
BioPharma Dive
Fri, 03/3/17 - 10:33 pm
FDA
Women's Health
heart disease
AMAG to hire 150 new sales reps to tout newly licensed women's health med Intarosa
Fierce Pharma
Wed, 02/15/17 - 09:52 am
Amag Pharmaceuticals
Women's Health
hirings
drug reps
Intarosa
vaginal pain
Women’s health biotech ObsEva sets terms for $87M IPO
Fierce Biotech
Wed, 01/18/17 - 10:01 am
IPOs
ObsEva
Women's Health
Drugmakers revive R&D focus on long stagnant women's health market
Medical Marketing and Media
Tue, 08/23/16 - 10:50 am
R&D
Women's Health
innovation
Myovant Sciences
Amgen
UCB Pharma
breast cancer
Pfizer
S1 Biopharma
Ibrance
Addyi

Pages